Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.1 (
protein kinase
)
81,284
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Two forms of the soluble calmodulin-dependent
protein kinase
type II can be isolated from rat brain: one oligomeric enzyme complex contains the alpha and beta subunits of the enzyme, whereas the other oligomeric species is comprised of a constant ratio of the subunits of the kinase and tubulin in the presence of several other minor polypeptides. The unassociated enzyme oligomer does not detectably exchange with the tubulin-containing form, and both forms rechromatograph by ion-exchange to their respective positions. In the molecular complex of proteins eluting at high ionic strength, the ratio of kinase subunits to tubulin remains constant throughout sedimentation velocity centrifugation and gel permeation chromatography. Furthermore, a similar complex of proteins is coprecipitated by the anti-kinase monoclonal antibody. Hydrodynamic parameters demonstrate that the tubulin-associated enzyme is larger than the unassociated enzyme, and displays heterodisperse behavior as well. Electron microscopic examination of negatively stained enzyme preparations reveals that the free enzyme constitutes uniform 10-20 nm diameter oligomers in contrast to the tubulin-associated kinase which forms elongated structures with varying morphology. Interestingly, enzyme purified through the calmodulin-Sepharose step can also form 'polymers' featuring ultrastructural similarities to postsynaptic densities and brain
microsomal
cytoskeletal preparations. We discuss the relevance of these observations to the ability of the type II calmodulin-dependent
protein kinase
to interact with other polypeptides and to form cytoskeletal structures such as the postsynaptic density.
...
PMID:Two types of brain calmodulin-dependent protein kinase II: morphological, biochemical and immunochemical properties. 283 88
Inhibitor-1 following phosphorylation by
protein kinase A
inhibits phosphoprotein phosphatase-1. We have found that in the rat heart inhibitor-1 is present only in the cytosolic fraction and that its phosphorylation in ventricular slices was increased by isoproterenol but not by isoproterenol and propranolol together. Cardiac
microsomal
phosphoprotein phosphatase activity, with added phosphorylase a as the substrate, was inhibited 33% by phosphorylated inhibitor-1. Phosphorylated inhibitor-1 decreased the dephosphorylation by exogenous phosphoprotein phosphatase-1 of phospholamban present in the sarcoplasmic reticulum membranes. These results suggest an interaction of cytoplasmic inhibitor-1 with either cytoplasmic or membrane-bound phosphoprotein phosphatase-1 with a subsequent effect on the level of phosphorylated phospholamban and the probable involvement of this interaction in the cardiac response to beta-adrenergic hormones.
...
PMID:A regulation of the level of phosphorylated phospholamban by inhibitor-1 in rat heart preparations in vitro. 283 40
We have previously reported an inhibition of the rat myometrial Na+/K+-ATPase by micromolar Ca2+ concentrations which was abolished by SDS treatment of the
microsomal
preparation. Application of dimethyl sulphoxide (DMSO) prevented this effect of SDS. In this report, we present our investigation into the mechanism of the inhibitory effect of Ca2+ on the myometrial Na+/K+-ATPase. We observed that, in parallel with inhibition by Ca2+, phosphorylation of a number of membrane components was abolished by SDS treatment of the microsome fraction. Exogenously added calmodulin had no effect. However, the catalytic subunit of
cAMP-dependent protein kinase
restored Ca2+ sensitivity of the Na+/K+-ATPase and phosphorylation of the other components. Furthermore, addition of the heat-stable protein kinase inhibitor reduced drastically the Ca2+ sensitivity of the Na+/K+-ATPase, as well as the phosphorylation of a number of proteins in the myometrial microsome fraction. It is concluded that the
cAMP-dependent protein kinase
may be involved in the modulation of Na+/K+-ATPase activity by Ca2+ in the myometrial plasma membrane.
...
PMID:Possible regulation of the myometrial Na+/K+-ATPase activity by Ca2+ and cAMP-dependent protein kinase. 283 4
The effects of the naturally occurring polyamines spermine and spermidine on phosphorylation promoted by cyclic AMP (cAMP)-dependent
protein kinase
(PK) (cAMP-PK; EC 2.7.1.37) were studied using the brain of the tobacco hornworm, Manduca sexta. Four particulate-associated peptides (280, 34, 21, and 19 kilodaltons) in day 1 pupal brains are endogenous substrates for a particulate type II cAMP-PK. These phosphoproteins are present in brain synaptosomal, as well as
microsomal
, particulate fractions but are not present in the cytosol. They are distributed throughout the CNS and PNS and are present in several nonneuronal tissues as well. Phosphorylation of these proteins via cAMP-PK was inhibited markedly by micromolar concentrations of spermine and spermidine. Other particulate-associated peptides phosphorylated via a Ca2+/calmodulin-PK or Ca2+ and cAMP-independent PKs were unaffected by polyamines, whereas the phosphorylation of a 260-kilodalton peptide was markedly enhanced. Spermine did not exert its inhibitory effect indirectly by enhancement of cAMP or ATP hydrolysis or via proteolysis, but its action appears to involve a substrate-directed inhibition of cAMP-PK-promoted phosphorylation as well as enhanced dephosphorylation. Although addition of spermine resulted in marked ribosome aggregation in synaptosomal and
microsomal
particulate fractions, this phenomenon was not involved in the inhibition of cAMP-PK-promoted phosphorylation.
...
PMID:Polyamines differentially inhibit cyclic AMP-dependent protein kinase-mediated phosphorylation in the brain of the tobacco hornworm, Manduca sexta. 284 97
Activation of H+ secretion by the gastric parietal cell involves major changes in morphology, metabolic activity and ion pathways of the secretory membrane. These changes are elicited by histamine binding to the H2 receptor, raising cAMP levels and presumably activating
cAMP-dependent protein kinase
. Concomitantly, the intracellular free Ca2+ concentration, [Ca2+]i, increases. Studies were performed to determine whether cAMP-mediated protein phosphorylation accompanies histamine activation of H+ secretion and to catalogue the major protein species serving as substrates for
cAMP-dependent protein kinase
in the parietal cell. 80% pure rabbit parietal cells, prepared by Nycodenz bouyant density centrifugation, were used. To investigate only cAMP-mediated effects, histamine-dependent changes in [Ca2+]i in these cells were abolished by depleting intracellular Ca2+ stores and performing experiments under Ca2+-free conditions. Acid secretion and steady-state levels of protein phosphorylation were then measured in unstimulated (cimetidine-treated) and histamine-stimulated cells. In intact parietal cells, concommitant with histamine stimulation of H+ secretion, increases in the level of protein phosphorylation were observed. Significantly changing phosphoproteins found in supernatant fractions showed apparent subunit sizes of approx. 148, 130, 47 and 43 kDa, and in
microsomal
fractions included those at approx. 130, 51 and 47 kDa. In parietal cell homogenates, using [gamma-32P]ATP, cAMP elicited significant phosphorylation of eight supernatant proteins and twelve
microsomal
proteins, which included the histamine-dependent phosphoproteins found in the intact parietal cell, except for the 51 kDa
microsomal
protein. As a working hypothesis, these proteins are involved in stimulus-secretion coupling in the parietal cell.
...
PMID:Gastric H+ secretion: histamine (cAMP-mediated) activation of protein phosphorylation. 284 75
The type-1 protein phosphatase associated with hepatic microsomes has been distinguished from the glycogen-bound enzyme in five ways. (1) The phosphorylase phosphatase/synthase phosphatase activity ratio of the
microsomal
enzyme (measured using muscle phosphorylase a and glycogen synthase (labelled in sites-3) as substrates) was 50-fold higher than that of the glycogen-bound enzyme. (2) The
microsomal
enzyme had a greater sensitivity to inhibitors-1 and 2. (3) Release of the catalytic subunit from the
microsomal
type-1 phosphatase by tryptic digestion was accompanied by a 2-fold increase in synthase phosphatase activity, whereas release of the catalytic subunit from the glycogen-bound enzyme decreased synthase phosphatase activity by 60%. (4) 95% of the synthase phosphatase activity was released from the microsomes with 0.3 M NaCl, whereas little activity could be released from the glycogen fraction with salt. (5) The type-1 phosphatase separated from glycogen by anion-exchange chromatography could be rebound to glycogen, whereas the
microsomal
enzyme (separated from the microsomes by the same procedure, or by extraction with NaCl) could not. These findings indicate that the synthase phosphatase activity of the
microsomal
enzyme is not explained by contamination with glycogen-bound enzyme. The
microsomal
and glycogen-associated enzymes may contain a common catalytic subunit complexed to
microsomal
and glycogen-binding subunits, respectively. Thiophosphorylase a was a potent inhibitor of the dephosphorylation of ribosomal protein S6, HMG-CoA reductase and glycogen synthase, by the glycogen-associated type-1 protein phosphatase. By contrast, thiophosphorylase a did not inhibit the dephosphorylation of S6 or HMG-CoA reductase by the
microsomal
enzyme, although the dephosphorylation of glycogen synthase was inhibited. The I50 for inhibition of synthase phosphatase activity by thiophosphorylase a catalysed by either the glycogen-associated or
microsomal
type-1 phosphatases, or for inhibition of S6 phosphatase activity catalysed by the glycogen-associated enzyme, was decreased 20-fold to 5-10 nM in the presence of glycogen. The results suggest that the physiologically relevant inhibitor of the glycogen-associated type-1 phosphatase is the phosphorylase a-glycogen complex, and that inhibition of the
microsomal
type-1 phosphatase by phosphorylase a is unlikely to play a role in the hormonal control of cholesterol or protein synthesis. Protein phosphatase-1 appears to be the principal S6 phosphatase in mammalian liver acting on the serine residues phosphorylated by
cyclic AMP-dependent protein kinase
.
...
PMID:Distinct type-1 protein phosphatases are associated with hepatic glycogen and microsomes. 284 6
The role of cAMP dependent regulation in thromboxane A2, prostacyclin and PGF2 alpha synthesis (measured by radioimmunoassay) was investigated in isolated mouse hepatocytes and in
microsomal
membranes prepared from these cells. In isolated hepatocytes N6,O2-dibutyryl cAMP inhibited the formation of all the three derivatives, while calcium ionophore A 23187 stimulated their synthesis. Addition of the dissociated catalytic subunit of cAMP dependent
protein kinase
and ATP to
microsomal
membranes inhibited the production of TXA2, PGI2 and PGF2 alpha by about 50% and this inhibition was counteracted by the combined addition of heat stable inhibitor protein of cAMP dependent
protein kinase
. It is concluded that in parenchymal liver cells cAMP dependent phosphorylation is directly involved in the inhibition of prostanoid synthesis.
...
PMID:cAMP dependent inhibition of thromboxane A2, prostacyclin and PGF2 alpha synthesis in mouse hepatocytes. 285 84
A subcellular fraction, highly enriched in uncoated vesicles (UCV) with high H+-ATPase (EC 3.6.1.34) activity, was isolated from the crude
microsomal
fraction of rat liver homogenates by discontinuous sucrose gradient centrifugation. The UCV fraction, recovered at the interface of sucrose density 1.08 and 1.10 g/ml, was shown morphologically to be a mixture of small, smooth-surfaced univesicular and a few multivesicular structures. A permeable anion (e.g. chloride) was required for internal acidification, indicating an electroneutral proton pump. Specific inhibitors of anion transport (pyridoxal 5'-phosphate and 4-acetamide-4'-isothiocyanostilbene-2,2'-disulfonic acid) totally inhibit proton translocation. The proton pump activity was insensitive to oligomycin, but was completely inhibited by about 5 microM of the tridentate bathophenanthroline chelate of Fe(II). The activity was also inhibited 100% by low concentrations of the protonophore carbonyl cyanide p-trifluoromethoxyphenylhydrazone, the proton conduction inhibitor N,N'-dicyclohexylcarbodiimide and the ionophore monensin. The UCV fraction contained 2 proteins of Mr 50000 (major) and 54000 (minor) which were phosphorylated by an endogenous cyclic nucleotide- and Ca2+-independent
protein kinase
.
...
PMID:Isolation from the microsomal fraction of rat liver of a subfraction highly enriched in uncoated endocytic vesicles with high H+-ATPase activity and a 50 kDa phosphoprotein. 286 70
Two hours after administration of Soman (120 micrograms/kg, s.c.), Sarin (150 micrograms/kg, s.c.), or Tabun (240 micrograms/kg, s.c.), microsomes and cytosol were prepared from rat striata. Microsomal and cytosolic calmodulin (CaM) levels,
microsomal
adenylate and guanylate cyclase activities,
protein kinase
activities, and Ca2+ + Mg2+-ATPase activities were determined while cytosolic phosphodiesterase (PDE) activities were determined. CaM levels in both cell fractions were significantly increased by Soman and Sarin. Cyclic AMP-PDE and adenylate cyclase activities were decreased by Soman and Sarin. All three agents decreased activities of cyclic GMP-PDE and guanylate cyclase. Sarin and Tabun administration caused significant increases in
microsomal
protein kinase
activity and none of the agents affected activity of divalent cation ATPases. The intensity of effects of the three organophosphates roughly paralleled their observed neurotoxic potencies. The results indicate that components of the CaM system are implicated as either causative or adaptive changes induced by these agents.
...
PMID:Acute effects of soman, sarin, and tabun on microsomal and cytosolic components of the calmodulin system in rat striatum. 286 34
A highly purified rat liver
protein kinase
phosphorylates and inactivates acetyl-CoA carboxylase, and causes rapid inactivation of
microsomal
HMG-CoA reductase in the presence of MgATP. Both effects are stimulated in an identical manner by AMP, and are greatly reduced by prior treatment of the kinase with purified protein phosphatase. The dephosphorylated kinase can be reactivated in the presence of MgATP, apparently due to a distinct kinase kinase, and this reactivation is stimulated by nanomolar concentrations of palmitoyl-CoA. These results show that a common, bicyclic
protein kinase
cascade can potently inactivate the regulatory enzymes of both fatty acid and cholesterol biosynthesis.
...
PMID:A common bicyclic protein kinase cascade inactivates the regulatory enzymes of fatty acid and cholesterol biosynthesis. 2462 16
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>